Skip to main content
. Author manuscript; available in PMC: 2024 Aug 1.
Published in final edited form as: J Heart Lung Transplant. 2023 Apr 23;42(8):1045–1053. doi: 10.1016/j.healun.2023.04.010

Table 3:

Univariate and Multivariate Cox-Regression Analyses for 5-Year Mortality Following Heart Retransplantation

Univariate Cox Analysis Multivariate Cox Analysis
Covariate Hazard Ratio 95% CI Hazard Ratio 95% CI
Heart-Kidney a at eGFR < 30mL/min/1.73m2 0.34 0.21 – 0.53 0.42 0.26 – 0.67
Heart-Kidney a at eGFR 30–45mL/min/1.73m2 0.31 0.14 – 0.70 0.29 0.13 – 0.65
Heart-Kidney a at eGFR > 45mL/min/1.73m2 0.95 0.44 – 2.08 0.68 0.30 – 1.54
Ageb 1.00 0.99 – 1.01 `0.99 0.99 – 1.01
BMIc 1.04 1.02 – 1.07 1.04 1.01 – 1.06
Waitlist durationd 1.00 0.99 – 1.01 1.00 1.00 – 1.01
Inter-transplant periodb 0.95 0.94 – 0.97 0.98 0.96 – 0.99
Female sex 1.21 0.95 – 1.56 1.16 0.89 – 1.51
Recipient race
 White reference reference reference reference
 Black 1.30 1.01 – 1.68 1.10 0.85 – 1.43
 Hispanic 1.11 0.78 – 1.56 1.03 0.74 – 1.43
 Others 0.96 0.59 – 1.57 0.92 0.55 – 1.53
Status 1A or Adult Status 1, 2 1.32 1.01 – 1.72 0.61 0.39 – 0.96
Dialysis prior to transplant 1.65 1.23 – 2.21 1.80 1.34 – 2.43
Recipient diabetes 1.37 1.07 – 1.74 1.26 0.97 – 1.64
Recipient cerebrovascular disease 0.87 0.48 – 1.57 0.77 0.43 – 1.39
Recipient history of malignancy 0.84 0.56 – 1.25 0.86 0.56 – 1.31
Inotrope dependency 1.44 1.16 – 1.79 1.16 0.93 – 1.43
Medical condition
 Home reference reference reference reference
 Hospitalized, non-ICU 1.08 0.77 – 1.51 1.27 0.82 – 1.97
 ICU 1.69 1.30 – 2.21 1.55 0.92 – 2.60
Ventricular assist device 1.44 0.93 – 2.22 0.97 0.66 – 1.43
Intra-aortic balloon pump 1.53 1.07 – 2.20 1.31 0.94 – 1.81
Functional Status
 Mild limitation reference reference reference reference
 Moderate limitation 1.88 1.23 – 2.86 1.83 1.19 – 2.81
 Severe Limitation 2.10 1.42 – 3.12 1.40 0.89 – 2.21
Donor ageb 1.02 1.01 – 1.02 1.02 1.01 – 1.03
Donor diabetes 1.12 0.63 – 2.00 0.95 0.48 – 1.90
Donor hypertension 1.62 1.18 – 2.21 1.38 0.95 – 2.01
Sex mismatch 1.12 0.89 – 1.42 1.15 0.86 – 1.55
Size mismatch (donor/recipient PHM ratio < 0.86) 0.77 0.50 – 1.16 0.58 0.38 – 0.89
Donor inotropic support 0.92 0.75 – 1.12 0.97 0.77 – 1.21
Donor LVEF < 50% 1.11 0.56 – 2.21 0.96 0.44 – 2.11
Ischemic timee 1.12 1.01 – 1.23 1.14 1.02 – 1.27
a

Comparisons made to isolated heart retransplant

b

per 1-year increase

c

per 1-unit increase;

d

per 1-day increase

e

per 1-hour increase

eGFR=estimated glomerular filtration rate; BMI=body mass index; ICU=intensive care unit; PHM=predicted heart mass; LVEF= left ventricular ejection fraction